[1]
|
Sieck, M.H. (1972) The role of the olfactory system in avoidance learning and activity. Physiology and Behavior, 8, 705-710.
http://dx.doi.org/10.1016/0031-9384(72)90099-6
|
[2]
|
Serby, M., Corwin, J., Conrad, P. and Rotrosen, J. (1985) Olfactory dysfunction in Alzheimer’s disease and Parkinson’s disease. The American Journal of Psychiatry, 142, 781-782.
|
[3]
|
Koss, E. (1986) Olfactory dysfunction in Alzheimer’s disease. Developmental Neuropsychology, 2, 89-99.
http://dx.doi.org/10.1080/87565648609540332
|
[4]
|
Esiri, M.M. and Wilcock, G.K. (1984) The olfactory bulbs in Alzheimer’s disease. Journal of Neurology, Neurosurgery and Psychiatry, 47, 56-60.
http://dx.doi.org/10.1136/jnnp.47.1.56
|
[5]
|
Doty, R.L. (1991) Olfactory capacities in aging and Alzheimer’s disease: Psychophysical and anatomic considerations. Annals of the New York Academy of Sciences, 640, 20-27.
|
[6]
|
Ferreira, G., Meurisse, M., Tillet, Y. and Lévy, F. (2001) Distribution and colocalization of choline acetyltransferase and p75 neurotrophin receptors in the sheep basal forebrain implications for the use of a specific cholinergic immunotoxin. Neuroscience, 104, 419-439.
http://dx.doi.org/10.1016/S0306-4522(01)00075-6
|
[7]
|
Han, F., Shioda, N., Moriguchi, S., Qin, Z.H. and Fukunaga, K. (2008) The vanadium (IV) compound rescues septohippocampal cholinergic neurons from neurodegeneration in olfactory bulbectomized mice. Neuroscience, 151, 671-679.
http://dx.doi.org/10.1016/j.neuroscience.2007.11.011
|
[8]
|
Nakajima, A., Yamakuni, T., Haraguchi, M., Omae, N., Song, S.Y., Kato, C., Nakagawasai, O., Tadano, T., Yokosuka, A. and Mimaki, Y. (2007) Nobiletin, a citrus flavonoid that improves memory impairment, rescues bulbectomy-induced cholinergic neurodegeneration in mice. Journal of Pharmacological Science, 105, 122-126.
http://dx.doi.org/10.1254/jphs.SC0070155
|
[9]
|
Han, F., Shioda, N., Moriguchi, S., Yamamoto, Y., Raie, A.Y., Yamaguchi, Y., Hino, M. and Fukunaga, K. (2008) Spiro[imidazo[1,2-a]pyridine-3,2-indan]-2(3H)-one (ZSET- 1446/ST101) treatment rescues olfactory bulbectomy-induced memory impairment by activating Ca2+/calmodulin kinase II and protein kinase C in mouse hippocampus. Journal of Pharmacology and Experimental Therapeutics, 326, 127-134.
http://dx.doi.org/10.1124/jpet.108.137471
|
[10]
|
Yamamoto, Y., Shioda, N., Han, F., Moriguchi, S. and Fukunaga, K. (2013) The novel cognitive enhancer ST101 enhances acetylcholine release in mouse dorsal hippocampus through T-type voltagegated calcium channel stimulation. Journal of Pharmacological Sciences, 121, 212-226. http://dx.doi.org/10.1254/jphs.12233FP
|
[11]
|
Aleksandrova, I.Y., Kuvichkin, V.V., Kashparov, I.A., Medvinskaya, N.I., Nesterova, I.V., Lunin, S.M., Samokhin, A.N., Bobkova, N.V. (2004) Increased level of beta- amyloid in the brain of bulbectomized mice. Biochemistry, 69, 176-180.
|
[12]
|
Winblad, B., Kilander, L., Eriksson, S., Minthon, L., Bats-man, S., Wetterholm, A.L., Jansson-Blixt, C. and Haglund, A. (2006) Donepezil in patients with severe Alzheimer’s disease: Double-blind, parallel-group, placebo-controlled study. Lancet, 367, 1057-1065.
http://dx.doi.org/10.1016/S0140-6736(06)68350-5
|
[13]
|
Seltzer, B. (2005) Donepezil: A review. Expert Opinion on Drug Metabolism and Toxicology, 1, 527-536.
http://dx.doi.org/10.1517/17425255.1.3.527
|
[14]
|
Naik, R.S., Hartmann, J., Kiewert, C., Duysen, E.G., Lockridge, O. and Klein, J. (2009) Effects of rivastigmine and donepezil on brain acetylcholine levels in acetylcho- linesterase-deficient mice. Journal of Pharmacy and Pharmaceutical Science, 12, 79-85.
|
[15]
|
Takada, Y., Yonezawa, A., Kume, T., Katsuki, H., Kaneko, S., Sugimoto, H. and Akaike, A. (2003) Nicotinic acetylcholine receptor-mediated neuroprotection by donepezil against glutamate neurotoxicity in rat cortical neurons. Journal of Pharmacology and Experimental Therapeutics, 306, 772-777. http://dx.doi.org/10.1124/jpet.103.050104
|
[16]
|
Akasofu, S., Kosasa, T., Kimura, M. and Kubota, A. (2003) Protective effect of donepezil in a primary culture of rat cortical neurons exposed to oxygen-glucose deprivation. European Journal of Pharmacology, 472, 57-63.
http://dx.doi.org/10.1016/S0014-2999(03)01865-X
|
[17]
|
Shen, H., Kihara, T., Hongo, H., Wu, X., Kem, W.R., Shimohama, S., Akaike, A., Niidome, T. and Sugimoto, H. (2010) Neuroprotection by donepezil against glutamate excitotoxicity involves stimulation of alpha7 nicotinic receptors and internalization of NMDA receptors. British Journal of Pharmacology, 161, 127-139.
http://dx.doi.org/10.1111/j.1476-5381.2010.00894.x
|
[18]
|
Yuan, H., Wang, W.P., Feng, N., Wang, L. and Wang, X.L. (2011) Donepezil attenuated oxygen-glucose deprivation insult by blocking Kv2.1 potassium channels. European Journal of Pharmacology, 657, 76-83.
http://dx.doi.org/10.1016/j.ejphar.2011.01.054
|
[19]
|
Saxena, G., Singh, S.P., Agrawal, R. and Nath, C. (2008) Effect of donepezil and tacrine on oxidative stress in intracerebral streptozotocin-induced model of dementia in mice. European Journal of Pharmacology, 581, 283-289.
http://dx.doi.org/10.1016/j.ejphar.2007.12.009
|
[20]
|
Min, D., Mao, X., Wu, K., Cao, Y., Guo, F., Zhu, S., Xie, N., Wang, L., Chen, T., Shaw, C. and Cai, J. (2012) Donepezil attenuates hippocampal neuronal damage and cognitive deficits after global cerebral ischemia in gerbils. Neuroscience Letters, 10, 29-33.
http://dx.doi.org/10.1016/j.neulet.2011.12.064
|
[21]
|
Hashimoto, M., Kazui, H., Matsumoto, K., Nakano, Y., Yasuda, M. and Mori, E. (2005) Does donepezil treatment slow the progression of hippocampal atrophy in patients with Alzheimer’s disease? The American Journal of Psychiatry, 162, 676-682.
http://dx.doi.org/10.1176/appi.ajp.162.4.676
|
[22]
|
Takada-Takatori, Y., Kume, T., Sugimoto, M., Katsuki, H., Sugimoto, H. and Akaike, A. (2006) Acetylcholinesterase inhibitors used in treatment of Alzheimer’s disease prevent glutamate neurotoxicity via nicotinic acetylcholine receptors and phosphatidylinositol 3-kinase cascade. Neuropharmacology, 51, 474-486.
http://dx.doi.org/10.1016/j.neuropharm.2006.04.007
|
[23]
|
Oda, T., Kume, T., Katsuki, H., Niidome, T., Sugimoto, H. and Akaike, A. (2007) Donepezil potentiates nerve growth factor-induced neurite outgrowth in PC12 cells. Journal of Pharmacological Science, 104, 349-354.
http://dx.doi.org/10.1254/jphs.FP0070563
|
[24]
|
Noh, M.Y., Koh, S.H., Kim, Y., Kim, H.Y., Cho, G.W. and Kim, S.H. (2009) Neuroprotective effects of donepezil through inhibition of GSK-3 activity in amyloid-beta- induced neuronal cell death. Journal of Neurochemistry, 108, 1116-1125.
http://dx.doi.org/10.1111/j.1471-4159.2008.05837.x
|
[25]
|
Toborek, M., Son, K.W., Pudelko, A., King-Pospisil, K., Wylegala, E. and Malecki, A. (2007) ERK 1/2 signaling pathway is involved in nicotine-mediated neuroprotection in spinal cord neurons. Journal of Cellular Biochemistry, 100, 279-292. http://dx.doi.org/10.1002/jcb.21013
|
[26]
|
Hozumi, S., Nakagawasai, O., Tan-No, K., Niijima, F., Yamadera, F., Murata, A., Arai, Y., Yasuhara, H. and Tadano, T. (2003) Characteristics of changes in cholinergic function and impairment of learning and memory-related behavior induced by olfactory bulbectomy. Behavioral Brain Research, 138, 9-15.
http://dx.doi.org/10.1016/S0166-4328(02)00183-3
|
[27]
|
Ennaceur, A. and Aggleton, J.P. (1997) The effects of neurotoxic lesions of the perirhinal cortex combined to fornix transection on object recognition memory in the rat. Behavioral Brain Research, 88, 181-193.
http://dx.doi.org/10.1016/S0166-4328(97)02297-3
|
[28]
|
Tyagi, E., Agrawal, R., Nath, C. and Shukla, R. (2010) Cholinergic protection via alpha7 nicotinic acetylcholine receptors and PI3K-Akt pathway in LPS-induced neuroinflammation. Neurochemistry International, 56, 135-142.
http://dx.doi.org/10.1016/j.neuint.2009.09.011
|
[29]
|
Azam, L., Winzer-Serhan, U. and Leslie, F.M. (2003) Co-expression of 7 and 2 nicotinic acetylcholine receptor subunit mRNAs within rat brain cholinergic neurons. Neuroscience, 119, 965-977.
http://dx.doi.org/10.1016/S0306-4522(03)00220-3
|
[30]
|
Thinschmidt, J.S., Frazier, C.J., King, M.A., Meyer, E.M. and Papke, R.L. (2005) Medial septal/diagonal band cells express multiple functional nicotinic receptor subtypes that are correlated with firing frequency. Neuroscience Letters, 389, 163-168.
http://dx.doi.org/10.1016/j.neulet.2005.07.038
|
[31]
|
Moriguchi, S., Yamamoto, Y., Ikuno, T. and Fukunaga, K. (2011) Sigma-1 receptor stimulation by dehydroepian-drosterone ameliorates cognitive impairment through activation of CaM kinase II, protein kinase C and extracellular signal-regulated kinase in olfactory bulbectomized mice. Journal of Neurochemistry, 117, 879-891.
http://dx.doi.org/10.1111/j.1471-4159.2011.07256.x
|
[32]
|
Ogura, H., Kosasa, T., Kuriya, Y. and Yamanishi, Y. (2000) Donepezil, a centrally acting acetylcholinesterase inhibitor, alleviates learning deficits in hypocholinergic models in rats. Methods and Findings in Experimental and Clinical Pharmacology, 22, 89-95.
http://dx.doi.org/10.1358/mf.2000.22.2.796070
|
[33]
|
Dong, H., Csernansky, C.A., Martin, M.V., Bertchume, A., Vallera, D. and Csernansky, J.G. (2005) Acetylcholinesterase inhibitors ameliorate behavioral deficits in the Tg2576 mouse model of Alzheimer’s disease. Psychopharmacology, 181, 145-152.
http://dx.doi.org/10.1007/s00213-005-2230-6
|
[34]
|
Van Dam, D., Abramowski, D., Staufenbiel, M. and De Deyn, P.P. (2005) Symptomatic effect of donepezil, rivastigmine, galantamine and memantine on cognitive deficits in the APP23 model. Psychopharmacology, 180, 177-190.
http://dx.doi.org/10.1007/s00213-004-2132-z
|
[35]
|
Kimura, M., Akasofu, S., Ogura, H. and Sawada, K. (2005) Protective effect of donepezil against Abeta(1-40) neurotoxicity in rat septal neurons. Brain Research, 1047, 72-84. http://dx.doi.org/10.1016/j.brainres.2005.04.014
|
[36]
|
Akasofu, S., Kimura, M., Kosasa, T., Sawada, K. and Ogura, H. (2008) Study of neuroprotection of donepezil, a therapy for Alzheimer’s disease. Chemico-Biological Interactions, 175, 222-226.
http://dx.doi.org/10.1016/j.cbi.2008.04.045
|
[37]
|
Akaike, A., Takada-Takatori, Y., Kume, T. and Izumi, Y. (2010) Mechanisms of neuroprotective effects of nicotine and acetylcholinesterase inhibitors: Role of alpha4 and alpha7 receptors in neuroprotection. Journal of Molecular Neuroscience, 40, 211-226.
http://dx.doi.org/10.1007/s12031-009-9236-1
|
[38]
|
Takada-Takatori, Y., Kume, T., Ohgi, Y., Izumi, Y., Niidome, T., Fujii, T., Sugimoto, H. and Akaike, A. (2008) Mechanism of neuroprotection by donepezil pretreatment in rat cortical neurons chronically treated with donepezil. Journal of Neuroscience Research, 86, 3575-3583.
http://dx.doi.org/10.1002/jnr.21798
|
[39]
|
Arias, E., Gallego-Sandín, S., Villarroya, M., García, A.G. and López, M.G. (2005) Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SH-SY5Y neuroblastoma cells role of nicotinic receptors. Journal of Pharmacology and Experimental Therapeutics, 315, 1346-1353.
http://dx.doi.org/10.1124/jpet.105.090365
|
[40]
|
Du, K. and Montminy, M. (1998) CREB is a regulatory target for the protein kinase Akt/PKB. Journal of Biological Chemistry, 273, 32377-32379.
http://dx.doi.org/10.1074/jbc.273.49.32377
|
[41]
|
Weeber, E.J. and Sweatt, J.D. (2002) Molecular neurobiology of human cognition. Neuron, 33, 845-848.
http://dx.doi.org/10.1016/S0896-6273(02)00634-7
|
[42]
|
Leyhe, T., Stransky, E., Eschweiler, G.W., Buchkremer, G. and Laske, C. (2008) Increase of BDNF serum concentration during donepezil treatment of patients with early Alzheimer’s disease. Journal of Alzheimer’s Disease, 16, 649-656.
|
[43]
|
Lindstrom, J. (1996) Neuronal nicotinic acetylcholine receptors. Ion Channels, 4, 377-450.
|
[44]
|
Roger, S.W., Gahring, L.C., Collins, A.C. and Marks, M. (1998) Age-related changes in neuronal nicotinic acetylcholine receptor subunit a4 expression are modified by long-term nicotine administration. The Journal of Neuroscience, 18, 4825-4832.
|
[45]
|
Liu, Q., Huang, Y., Xue, F., Simard, A., DeChon, J., Li, G., Zhang, J., Lucero, L., Wang, M., Sierks, M., Hu, G., Chang, Y., Lukas, R.J. and Wu, J. (2009) A novel nicotinic actylcholine receptor subtype in basal forebrain cholinergic neurons with high sensitivity to amyloid peptides. The Journal of Neuroscience, 29, 918-929.
http://dx.doi.org/10.1523/JNEUROSCI.3952-08.2009
|
[46]
|
Pugazhenthi, S., Nesterova, A., Sable, C., Heidenreich, K.A., Boxer, L.M., Heasley, L.E. and Reusch, J.E. (2000) Akt/protein kinase B up-regulates Bcl-2 expression through cAMP-response element-binding protein. Journal of Biological Chemistry, 275, 10761-10766.
http://dx.doi.org/10.1074/jbc.275.15.10761
|
[47]
|
Hao, Y., Creson, T., Zhang, L., Li, P., Du, F., Yuan, P., Gould, T.D., Manji, H.K. and Chen, G. (2004) Mood stabilizer valproate promotes ERK pathway-dependent cortical neuronal growth and neurogenesis. Journal of Neuroscience, 24, 6590-6599.
http://dx.doi.org/10.1523/JNEUROSCI.5747-03.2004
|
[48]
|
Greer, P.L. and Greenberg, M.E. (2008) From synapse to nucleus: Calcium-dependent gene transcription in the control of synapse development and function. Neuron, 59, 846-860.
http://dx.doi.org/10.1016/j.neuron.2008.09.002
|
[49]
|
Autio, H., Matlik, K., Rantamaki, T., Lindemann, L., Hoener, M.C., Chao, M., Arumae, U. and Castrén, E. (2011) Acetylcholinesterase inhibitors rapidly activate Trk neurotrophin receptors in the mouse hippocampus. Neuropharmacology, 61, 1291-1296.
http://dx.doi.org/10.1016/j.neuropharm.2011.07.033?
|